NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-239-2009-0-US-03 DNA-Protein Vaccination Protocols US National Stage 13/580,892 Abandoned
NCI E-161-2010-0-US-06 PROGNOSTIC MARKERS AND METHODS FOR PROSTATE CANCER US National Stage 13/641,066 Abandoned
CC E-013-2013-0-US-01 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND US 61/713,132 Abandoned
NCI E-181-2006-0-AU-14 Micro-RNA Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer AU DIV 2012238336 Abandoned
NIA E-189-2003-0-US-16 Thiothalidomides: Novel Isoteric Analogues Of Thalidomide With Enhanced TNF-a Inhibitory Activity US CON 13/648,625 8853253 Abandoned PDF
NCI E-239-2011-0-PCT-02 Thioxothiazolidinone Derivatives Useful As Inhibitors Of TDP1 PCT PCT PCT/US1259515 Abandoned
NHLBI E-261-2012-0-US-01 Imaging Methods and Computer-Readable Media US 61/711,702 Abandoned
NCI E-268-2012-0-US-03 Discovery Of Niclosamide As A Lead For Inlnbition Of S100A4 Transcription And Metastasis US National Stage 14/112,521 Abandoned
NIDCR E-282-2009-0-US-05 SUSTAINED RELEASE DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF HEAD AND NECK CANCERS US National Stage 13/391,756 10485792 Issued PDF
NCI E-217-2011-0-PCT-02 GENETIC MARKER FOR PREDICTING PROGNOSIS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS PCT PCT PCT/US2012/59048 Expired
NCATS E-217-2013-0-US-01 A new chemical entity useful for treating various diseases US 61/710,505 Abandoned
NIAID E-089-2012-0-US-01 A Formulation Of Mycobacterial Components As An Adjuvant For Inducing Th17 Response US 61/709,713 Abandoned
NCI E-269-2009-0-RU-09 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity RU National Stage 2012114005 Abandoned
NCI E-197-2011-0-PCT-02 Use Of MIRNA126 To Produce Hematopoietic Stem Cells PCT PCT PCT/US12/000472 Abandoned
NIAID E-158-2007-3-US-03 LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE US DIV 13/633,633 9255252 Abandoned PDF
NCI E-034-2010-0-US-03 B- Mannosylceramide And Stimulation Of NKT Cell Anti-Tumor Immunity US National Stage 13/582,612 8835613 Issued PDF
NHGRI E-242-2012-0-US-01 Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma US 61/708,785 Abandoned
NCI E-191-2002-0-US-10 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US CON 13/632,293 8609716 Expired PDF
NIAID E-102-2014-1-US-01 Clonal Lineage Of CD4 Binding Site Antibodies For Use As Templates For HIV-1 Vaccine Design US 61/708,413 Abandoned
NIAID E-103-2014-1-US-01 Antibody Evolution Immunogens US 61/708,466 Abandoned
NICHD E-271-2011-0-PCT-02 Influenza Vaccine PCT PCT PCT/US2012/057863 Expired
NINDS E-143-2002-1-JP-14 Method For the Treatment of Multiple Sclerosis JP DIV 2012-217520 Abandoned
NINDS E-249-2011-0-PCT-02 Method of Treating Multiple Sclerosis By Intrathecal Depletion Of B Cells And Biomarkers To Select Patients With Progressive Multiple Sclerosis PCT PCT PCT/US2012/057583 Expired
NINDS E-249-2011-0-EP-03 Method of Treating Multiple Sclerosis By Intrathecal Depletion Of B Cells And Biomarkers To Select Patients With Progressive Multiple Sclerosiss EP National Stage 12769299.4 Abandoned
NCI E-236-2012-0-US-01 Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity US 61/706,396 Abandoned
NCI E-261-2005-2-US-04 Method For Diagnosing And Monitoring The Progression Of Cancer US CON 13/627,595 8617831 Issued PDF
NCI E-147-2012-2-PCT-01 Methods Of Treating Periodontal Inflammation And Periodontal Bone Loss PCT PCT COMB PCT/US12/057329 Expired
NHLBI E-214-2012-0-US-01 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY US 61/705,555 Abandoned
NIDCR E-232-2011-1-US-01 Methods For The Diagnosis And Treatment Of Sjogren's Syndrome US 61/705,517 Abandoned
NIAID E-293-2011-2-IN-05 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES IN National Stage 3192/DELNP/2014 Issued
NIAID E-293-2011-2-CA-02 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES CA National Stage 2849822 Issued
NIAID E-293-2011-2-IE-13 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES IE EP 12834398.5 Issued
NIAID E-293-2011-2-IT-14 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES IT EP 12834398.5 Issued
NIAID E-293-2011-2-BE-08 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES BE EP 12834398.5 Issued
NIAID E-293-2011-2-DE-10 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES DE EP 12834398.5 Issued
NIAID E-293-2011-2-FR-11 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES FR EP 12834398.5 Issued
NIAID E-293-2011-2-GB-12 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES GB EP 12834398.5 Issued
NIAID E-293-2011-2-CH-09 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES CH EP 12834398.5 Issued
NIAID E-293-2011-2-EP-04 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES EP National Stage 12834398.5 Issued
NIAID E-293-2011-2-CN-03 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES CN National Stage 201280057703.7 Issued
NICHD E-042-2013-0-US-03 Injectable Dendrimer Hydrogel Nanoparticles US National Stage 13/636,715 9526794 Issued PDF
NIAID E-293-2011-2-PCT-01 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES PCT PCT COMB PCT/US2012/56822 Expired
NIA E-012-2012-0-EP-09 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders EP National Stage 12761739.7 Issued
NIA E-012-2012-0-JP-06 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders JP National Stage 2014-531244 Issued
NIA E-012-2012-0-AU-03 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders AU National Stage 2012311483 Issued
NIA E-012-2012-0-CN-05 Combination Therapy Using Immunoglobulin and C1-inhibitor CN National Stage 201280046349.8 Issued
NIA E-012-2012-0-PCT-02 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders PCT PCT PCT/EP12/068643 Expired
NICHD E-057-2008-0-US-14 Method for Treating Uterine Fibroids US CON 13/622,892 8722653 Issued PDF
NCI E-340-2007-0-US-09 Human Prostate Cancer MicroRNA Signature US DIV 13/622,487 Abandoned
NIAID E-285-2012-0-US-01 I0E8-Epitope-Based Immunogens And Probes And Their Uses US 61/702,703 Abandoned